Heron Therapeutics: Q4 Earnings Insights

Heron Therapeutics HRTX reported its Q4 earnings results on Tuesday, March 12, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Heron Therapeutics beat estimated earnings by 56.00000000000001%, reporting an EPS of $-0.07 versus an estimate of $-0.16.

Revenue was up $4.21 million from the same period last year.

Last quarter the company beat on EPS by $0.12 which was followed by a 59.0% increase in the share price the next day.

Here's a look at Heron Therapeutics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.29	-0.23	-0.20	-0.28
EPS Actual	-0.17	-0.35	-0.27	-0.17
Revenue Estimate	32.75M	31.70M	29.69M	26.90M
Revenue Actual	31.43M	31.76M	29.61M	30.03M

To track all earnings releases for Heron Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar